natgillin/translations-raw huggingface dataset:
Det frarådes at give Stelara til børn under 18 år med Crohns sygdom, da det ikke er undersøgt hos denne aldersgruppe.
Stelara is not recommended for use in children under 18 years of age with Crohn’s disease because it has not been studied in this age group.
Det frarådes at indgive
It is not recommended to
Det frarådes at kombinere Thymanax og alkohol.
The combination of Thymanax and alcohol is not advisable.
Det frarådes at kombinere Valdoxan og alkohol.
The combination of Valdoxan and alcohol is not advisable.
Det frarådes at påbegynde behandling hos patienter, som ikke tidligere er behandlet med RoActemra og som har et absolut neutrofilocyttal under 2 x 109/l.
In patients not previously treated with RoActemra, initiation is not recommended in patients with an absolute neutrophil count (ANC) below 2 x 109/l.
Det frarådes at tage Aloxi i dagene efter kemoterapi, medmindre De får en ny kemoterapicyklus.
It is not recommended to take Aloxi in the days following chemotherapy unless you are receiving another chemotherapy cycle.
Det frarådes at tage Cotellic under graviditet – selvom Cotellic ikke er undersøgt hos gravide kvinder, kan det muligvis skade det ufødte barn og forårsage misdannelser.
Cotellic is not recommended during pregnancy - although the effects of Cotellic have not been studied in pregnant women, it may cause permanent harm or birth defects to an unborn baby.
Det frarådes at tage Isentress sammen med visse lægemidler mod for meget mavesyre (de der indeholder aluminium og/eller magnesium).
It is not recommended to take ISENTRESS with certain antacids (those containing aluminium and/or magnesium).
Det frarådes at tage medicinen i mere end 10 dage, da dens virkning på stoppet næse efterhånden kan aftage.
Treatment for more than 10 days is not advisable, as the medicine’s effects on nasal congestion may wear off.
Det frarådes at tage Palonosetron Accord i dagene efter kemoterapi, medmindre De får en ny kemoterapicyklus.
It is not recommended to take palonosetron accord in the days following chemotherapy unless you are receiving another chemotherapy cycle.
Det frarådes at tage Rapamune samtidig med rifampicin, ketoconazol og voriconazol
It is not recommended that Rapamune be taken with rifampicin, ketoconazole or voriconazole.
Det frarådes derfor at anvende andre vacciner eller veterinære lægemidler umiddelbart før og efter brugen.
A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Det frarådes derfor at anvende andre vacciner inden for 14 dage inden eller efter vaccinationen med dette lægemiddel.
It is therefore recommended that no other vaccine should be administered within 14 days before or after vaccination with this product.
Det frarådes derfor at anvende produktet under drægtighed og diegivning.
Therefore the use of the product during pregnancy and lactation is not recommended.
Det frarådes derfor at indgive aminophyllin udelukkende med henblik på at standse et krampeanfald, der er udløst af Rapiscan.
Therefore administration of aminophylline solely for the purpose of terminating a seizure induced by Rapiscan is not recommended.
Det frarådes derfor at vaccinere føl under 6 måneder.
It is therefore recommended not to vaccinate foals of less than 6 months of age.
Det frarådes derfor kvinder, der ammer, at bruge Rasilamlo.
It is therefore not recommended for women who are breast-feeding to use Rasilamlo.
Det frarådes derfor, at anvende oxybutynin i amningsperioden.
Use of oxybutynin while breast-feeding is therefore not recommended.
Det frarådes kun at bruge fibrinklæber frem for sting til at fastgøre implantatet.
Using fibrin glue only, instead of stitches, to secure the implant is not recommended.
Det frarådes mandlige patienter, der behandles med Paxene, at få børn under og op til 6 måneder efter behandlingen.
Male patients treated with Paxene are advised not to father a child during and up to six months after treatment.
Det frarådes, at børn og unge under 18 år bruger Azarga.
AZARGA is not recommended for children and adolescents under 18 years.
Det frarådes, at De ammer Deres barn, mens De tager Vimpat, da man ikke ved, om Vimpat går over i modermælk.
It is not recommended to breast-feed your baby while taking Vimpat, as it is not known if Vimpat passes into the breast milk.
Det frarådes, at De tager Vimpat, hvis De er gravid, da man ikke ved, hvilken virkning Vimpat har på graviditeten og det ufødte barn.
It is not recommended to take Vimpat if you are pregnant, as the effects of Vimpat on pregnancy and the unborn baby are not known.
Det frarådes, at du tager Aerius, hvis du er gravid, eller hvis du ammer dit spædbarn.
Taking Aerius oral solution is not recommended if you are pregnant or nursing a baby.
Det frarådes, at du tager Azomyr, hvis du er gravid, eller hvis du ammer dit spædbarn.
Taking Azomyr oral solution is not recommended if you are pregnant or nursing a baby.
Det frarådes, at du tager Neoclarityn, hvis du er gravid, eller hvis du ammer dit spædbarn.
Taking Neoclarityn oral solution is not recommended if you are pregnant or nursing a baby.
Det frarådes, at kønsmodne mænd gør en kvinde gravid under behandlingen og i op til 6 måneder efter behandlingen.
Sexually mature males are advised not to father a child during the treatment, and up to 6 months thereafter.
Det fremgik af disse studier, at næsten alle mus, der havde en neutraliserende plaque- reduktionsprøvetiter på mindst 1:10, var beskyttet mod et dødeligt angreb fra japansk encefalitisvirus.
These studies showed that almost all mice that had a Plaque Reduction Neutralization Test titre of at least 1:10 were protected from a lethal Japanese encephalitis virus challenge.
Det fremgik af prækliniske og kliniske studier, at deferasirox dispergible tabletter kunne være ligeså aktive som deferoxamin, når de blev administreret i en dosisratio på 2:1 (det vil sige en dosis deferasirox dispergible tabletter, der numerisk er halvdelen af deferoxamindosis).
It appeared from preclinical and clinical studies that deferasirox dispersible tablets could be as active as deferoxamine when used in a dose ratio of 2:1 (i.e. a dose of deferasirox dispersible tablets that is numerically half of the deferoxamine dose).
Det fremgår af data fra in vitro- forsøg (opløsning af det aktive stof og test af hudgennemtrængning), at hastigheden af capsaicin- frigivelse fra Qutenza er lineær i løbet af applikationstiden.
In vitro data (active substance dissolution and skin permeation assays) demonstrate that the rate of release of capsaicin from Qutenza is linear during the application time.
Det fremgår af faglitteraturen, at collagenmembraner, der fås i handelen, kan anvendes som alternativ til periost under ACI- procedurer.
Scientific publications have shown that commercially available collagen membranes can be used as an alternative to the periost in ACI procedures.
Det fremkomne, rekonstituerede Myocet-præparat indeholder 50 mg doxorubicin HCl/25 ml koncentrat til liposom-dispersion til infusionsvæske (2 mg/ml).
The resulting reconstituted preparation of Myocet contains 50 mg of doxorubicin HCl/25 ml of concentrate for liposomal dispersion for infusion (2 mg/ml).
Det fremkomne, rekonstituerede Myocet-præparat indeholder 50 mg doxorubicin HCl/25 ml liposom- dispersion (2 mg/ml).
The resulting reconstituted preparation of Myocet contains 50 mg of doxorubicin HCl/25 ml of liposomal dispersion (2 mg/ml).
Det fremmer væksten i barndommen og ungdommen og har desuden betydning for protein-, fedtstof- og
It promotes growth during childhood and adolescence, and also acts on the way the body handles proteins, fat and
Det fremstilles ved "rekombinant DNA-teknologi": Hormonet produceres af en bakterie, der har fået indsat et gen (DNA), som sætter den i stand til at producere dette hormon.
It is produced by a method known as ‘recombinant DNA technology’: the hormone is made by a bacterium which has received a gene (DNA) that makes it able to produce it.
Det fremstilles ved "rekombinant DNA-teknologi": Hormonet produceres ved dyrkning af gærceller, der har fået indsat et gen (DNA), som gør dem i stand til at producere det.
It is produced by a method known as ‘recombinant DNA technology’: the hormone is made by yeast cells into which a gene (DNA) has been introduced that makes them able to produce it.
Det fremstilles ved hjælp af en metode kaldet "rekombinant dna-teknologi": Enzymet fremstilles af celler, der har fået indsat et gen (DNA), som gør dem i stand til at producere laronidase.
It is produced by a method known as ‘recombinant DNA technology’: the enzyme is made by cells into which a gene (DNA) has been introduced that makes them able to produce laronidase.
Det fremstilles ved hjælp af en metode kaldet »rekombinant dna-teknologi«: Det fremstilles af en celle, som har modtaget et gen (DNA), der sætter den i stand til at producere epoetin zeta.
It is produced by a method known as ‘recombinant DNA technology’: it is made by a cell that has received a gene (DNA), which makes it able to produce epoetin zeta.
Det fremstilles ved hjælp af en metode kaldet ‘rekombinant dna-teknologi’: Det fremstilles af en celle, som har modtaget et gen (DNA), der sætter den i stand til at danne epoetin zeta.
It is produced by a method known as ‘recombinant DNA technology’: it is made by a cell that has received a gene (DNA), which makes it able to produce epoetin zeta.
Det fremstilles ved hjælp af en metode kaldet ”rekombinant dna-teknologi”, hvorved en bakterie får indsat et gen (dna), så den bliver i stand til at producere anakinra.
It is produced by a method known as ‘recombinant DNA technology’: it is made by a bacterium into which a gene (DNA) has been introduced, which makes it able to produce anakinra.
Det fremstilles ved hjælp af en metode kaldet ”rekombinant dna-teknologi”: Hormonet fremstilles af gær, som har modtaget et gen (DNA), der gør det i stand til at fremstille somatropin.
It is produced by a method known as ‘recombinant DNA technology’: the hormone is made by a yeast that has received a gene (DNA) that makes it able to produce somatropin.
Det fremstilles ved hjælp af en metode, der kaldes "rekombinant DNA-teknologi", dvs. det fremstilles af en celle, som har modtaget et gen (DNA), der sætter den i stand til at danne epoetin theta.
It is produced by a method known as ‘recombinant DNA technology’: it is made by a cell that has received a gene (DNA), which makes it able to produce epoetin theta.
Det frigiver pulveret i kapslen, når du trækker vejret ind.
This lets the powder in the capsule be released when you breathe in.
Det frysetørrede pulver bør inden opløsning, filtrering og fortynding nå en temperatur på mellem ca.
The lyophilised powder should be allowed to reach a temperature between approximately 20C – 25°C prior to reconstitution, filtering using the filter provided and dilution.
Det frysetørrede pulver skal rekonstitueres med 1 ml af det specifikke fortyndingsmiddel for at opnå, afhængig af pakningen, en suspension indeholdende 10 MU rekombinant interferon.
The freeze-dried fraction must be reconstituted with 1 ml of the specific diluent to obtain a solution containing 10 MU of recombinant interferon.
Det frysetørrede pulver skal rekonstitueres med 1 ml af det specifikke fortyndingsmiddel for at opnå, afhængig af pakningen, en suspension indeholdende 5 MU eller 10 MU rekombinant interferon.
The freeze-dried fraction must be reconstituted with 1 ml of the specific diluent to obtain, depending on the presentation, a suspension containing 5 MU or 10 MU of recombinant interferon.
Det frysetørrede pulver skal rekonstitueres med 1 ml af det specifikke fortyndingsmiddel for at opnå, afhængig af pakningen, en suspension indeholdende 5 MU rekombinant interferon.
The freeze-dried fraction must be reconstituted with 1 ml of the specific diluent to obtain a solution containing 5 MU of recombinant interferon.
Det frysetørrede pulver til injektionsvæske skal rekonstitueres med den medfølgende solvens [0,9 % (9 mg/ml) natriumchlorid-injektionsvæske] fra den fyldte injektionssprøjte under anvendelse af den sterile hætteglasadapter til rekonstituering.
The vial of lyophilised product powder for injection must be reconstituted with the supplied solvent [sodium chloride 9 mg/mL (0.9%) solution] from the pre-filled syringe using the sterile vial adapter reconstitution device.
Det fuldstændige produktresumé for Cuprymina er vedlagt produktpakken for at give sundhedspersoner yderligere videnskabelig og praktisk information om produktets anvendelse.
The complete Summary of Product Characteristics (SmPC) of Cuprymina is provided as a separate document in the product pack, with the objective to provide healthcare professionals with other additional scientific and practical information about the use of this product.
Det fuldstændige produktresumé for EndolucinBeta er vedlagt som et separat dokument i pakningen for at give sundhedspersoner yderligere videnskabelig og praktisk information om anvendelsen af dette radioaktive lægemiddel.
The complete SmPC of EndolucinBeta is provided as a separate document in the product package, with the objective to provide healthcare professionals with other additional scientific and practical information about the administration and use of this radiopharmaceutical.
Det fuldstændige produktresumé for Lymphoseek medfølger som en afrivningsfolder sidst i den trykte ind- lægsseddel i pakningen, så læger og sundhedspersonale kan få supplerende videnskabelige og praktiske op- lysninger om administration og anvendelse af dette radioaktive lægemiddel.
The complete SmPC of Lymphoseek is provided as a tear-off section at the end of the printed leaflet in the product package, with the objective to provide healthcare professionals with other additional scientific and practical information about the administration and use of this radiopharmaceutical.
Det fuldstændige produktresumé for Quadramet leveres som et separat dokument i produktpakningen med henblik på at give sundhedspersonalet yderligere videnskabelige og praktiske oplysninger om administration og brug af dette radioaktive lægemiddel.
The complete SmPC of Quadramet is provided as a separate document in the product package, with the objective to provide healthcare professionals with other additional scientific and practical information about the administration and use of this radiopharmaceutical.
Det fuldt rekonstituerede produkt fremstår klart og der er eventuelt et par små bobler eller skum langs kanten på hætteglasset.
The fully reconstituted product will appear clear and may have a few small bubbles or foam around the edge of the vial.
Det fungerer som mitosestimulerende faktor og differentieringshormon.
It acts as a mitosis stimulating factor and differentiation hormone
Det fungerer som mitosestimulerende faktor og differentieringshormon.
It acts as a mitosis stimulating factor and differentiation hormone.
Det får arterierne i hjertet til at udvide sig og forøger pulsen, hvilket får mere blod til at løbe til hjertets muskulatur.
This makes more blood flow to the muscles of the heart.
Det får blodpladerne til at holde op med at "klæbe sammen", hvilket mindsker risikoen for, at der opstår en blodprop, og er med til at forebygge endnu et hjerteanfald eller slagtilfælde.
This stops the platelets becoming ‘sticky’, reducing the risk of a blood clot forming and helping to prevent another heart attack or stroke.
Det får blodpladerne til at holde op med at "klæbe sammen", hvilket mindsker risikoen for, at der opstår en blodprop, og er med til at forebygge et slagtilfælde eller endnu et hjerteanfald.
This stops the platelets becoming ‘sticky’, reducing the risk of a blood clot forming and helping to prevent a stroke or another heart attack.
Det får du at vide af din læge på baggrund af resultaterne af din sidste blodprøve.
Your doctor will tell if this applies to you based on the results of your last blood test.
Det får kræftcellerne til at dele sig langsommere, men har kun ringe virkning på normale celler.
This results in the growth of cancer cells being reduced, while normal cells are only slightly affected.
Det får pulveret til at opløses hurtigere.
This may reduce the time it takes for the powder to dissolve.
Det fås i en fyldt injektionssprøjte (200 mg/ml).
It is available in a pre-filled syringe (200 mg/ml).
Det fås i en fyldt injektionssprøjte, som hver indeholder 6 mg pegfilgrastim.
It is available in a pre-filled syringe containing 6 mg pegfilgrastim.
Det fås i engangshætteglas indeholdende 120 mg denosumab.
It is available in single- use vials containing 120 mg denosumab.
Det fås i enkeltdosis-beholdere og flerdosis-beholdere.
It is available in single-dose containers and in multidose containers.
Det fås i form af to opløsninger: Den ene indeholder det aktive stof humant koagulabelt protein (50 til 90 mg/ml), og den anden det aktive stof human trombin (800 til 1 200 internationale enheder pr. ml.).
It is available as two solutions, one containing the active substance human clottable protein (50 to 90 mg/ml), and the other containing the active substance human thrombin (800 to 1200 international units per millilitre).
Det fås i fyldte injektionssprøjter eller i hætteglas, som hver indeholder 60 mg denosumab.
It is available in prefilled syringes or in vials, each of which contains 60 mg denosumab.
Det fås i fyldte injektionssprøjter, som indeholder mellem 1 000 og 40 000 internationale enheder (IE) af det aktive stof epoetin zeta.
It is available in prefilled syringes containing between 1,000 and 40,000 international units (IU) of the active substance epoetin zeta.
Det fås i fyldte injektionssprøjter, som indeholder mellem 1 000 og 40 000 internationale enheder (IE) af det aktive stof, epoetin alfa.
It is available in pre-filled syringes that contain between 1,000 and 40,000 international units (IU) of the active substance, epoetin alfa.
Det fås i hætteglas eller i fyldte injektionssprøjter.
It is available in vials or in prefilled syringes.
Det fås i pakninger med 1 hætteglas med 50 ml.
It is available in packs of 1 vial of 50 mL
Det fås i pakninger med:
It is available in packs of:
Det fås som 4 mg- og 8 mg- depottabletter.
It is available as prolonged-release 4 mg tablets and 8 mg tablets.
Det fås som breve på 250 mg, som hver indeholder 9,375 mg imiquimod (3,75 %).
It is available as 250 mg sachets, each containing 9.375 mg imiquimod (3.75%).
Det fås som bukkaltabletter (tabletter, der opløses i munden).
It is available as ‘buccal tablets’ (tablets that dissolve in the mouth).
Det fås som en 4 mg/ml oral opløsning.
It is available as a 4 mg/ml oral solution.
Det fås som en depotinjektionsvæske, suspension, i fyldte injektionssprøjter (25, 50, 75, 100 og 150 mg).
It is available as a prolonged- release suspension for injection in pre-filled syringes (25, 50, 75, 100 and 150 mg).
Det fås som en injektionsvæske, opløsning, i fyldte sprøjter eller hætteglas.
It is available as a solution for injection in prefilled syringes or vials.
Det fås som en injektionsvæske, suspension, der indeholder dele af bakterien
It is available as a suspension for injection that contains parts of the bacterium
Det fås som en injektionsvæske, suspension, der indeholder dele af inaktiveret (dræbt) influenzavirus.
It is available as a suspension for injection that contains some parts of inactivated (killed) influenza (flu) virus.
Det fås som en klar, farveløs til gul opløsning i form af spot-on-pipetter, der allerede er fyldt med den rette mængde Activyl til behandling af én kat eller én hund, afhængig af dyrets vægt (pipetterne leveres i forskellige størrelser til forskellige vægtklasser, fem for hunde og to for katte).
It is available as a clear, colourless to yellow solution presented as a ‘spot-on’ in pipettes already filled with the correct amount of Activyl needed to treat one cat or dog depending on its weight (5 sizes of pipettes for different dog weights and 2 sizes of pipettes for different cat weights).
Det fås som en oliesuspension, der indeholder 0,9 mg/ml emodepsid og 18 mg/ml toltrazuril.
It is available as an oily suspension, containing 0.9 mg/ml emodepside and 18 mg/ml toltrazuril.
Det fås som en opløsning til injektion i øjet i fyldte sprøjter eller hætteglas.
It is available as a solution for injection into the eye in pre-filled syringes or vials.
Det fås som en oral opløsning (1 mg/ml) og tabletter (0,5 mg, 1 mg og 2 mg).
It is available as an oral solution (1 mg/ml) and tablets (0.5 mg, 1 mg and 2 mg).
Det fås som en oral suspension (200 mg/ml) til brug i drikkevand til svin og kyllinger.
It is available as an oral suspension (200 mg/ml) for use in drinking water for pigs and chickens.
Det fås som en premix til medicineret foder til svin (0,5 %, 10 % og 50 %) og kaniner (10 %) og som et oralt pulver til svin (10 %).
It is available as a premix for medicated feeding stuff for pigs (0.5%, 10% and 50%) and rabbits (10%), and as an oral powder for pigs (10%).
Det fås som en spot-on-opløsning i pipetter, som allerede er fyldt med den korrekte mængde til at behandle en hund, afhængig af dens vægt.
It is available as a ‘spot-on’ solution in pipettes already filled with the correct amount needed to treat one dog depending on its weight.
Det fås som en ”mundhulevæske, opløsning” (en opløsning, som gives i siden af munden i hulrummet mellem gummerne og kinden) i fyldte sprøjter.
It is available as ‘oromucosal solution’ (a solution given in the side of the mouth, into the space between the gum and the cheek) in prefilled syringes.
Det fås som et inhalationspulver i en bærbar inhalator, og hver inhalation giver en fast dosis af lægemidlet.
It is available as an inhalation powder in a portable inhaler device; each inhalation provides a fixed dose of the medicine.
Det fås som et koncentrat og en solvens, der anvendes til at fremstille en væske til infusion (drop) i en vene.
It is available as a concentrate and a solvent to be made up into a solution for infusion (drip) into a vein.
Det fås som et koncentrat til infusionsvæske, opløsning (drop i en vene).
It is available as a concentrate to be made up into a solution for infusion (drip into a vein).
Det fås som et koncentrat, der blandes til en opløsning til infusion (drop i en vene).
It is available as a concentrate that is made up into a solution for infusion (drip) into a vein.
Det fås som et oralt pulver (50 mg per gram) og som tabletter (250 mg).
It is available as an oral powder (50 mg per gram) and as tablets (250 mg).
Det fås som et pulver (150 mg), der anvendes til fremstilling af en injektionsvæske, opløsning.
It is available as a powder (150 mg) that is made up into a solution for injection.
Det fås som et pulver (25 mg) til fremstilling af en suspension til indtagelse gennem munden.
It is also available as a powder (25 mg) to prepare a suspension to be taken by mouth.
Det fås som et pulver og en solvens, der blandes til en depotinjektionsvæske, opløsning, som indeholder 2 mg exenatid.
It is available as a powder and solvent that are mixed together to make a prolonged-release suspension for injection that provides 2 mg of exenatide.
Det fås som et pulver, der anvendes til fremstilling af en injektionsopløsning, og injiceres af en sundhedsperson under huden på overarmen, låret eller maven en gang hver 4. uge.
It is available as a powder to make up a solution for injection, and is injected by a healthcare professional under the skin of the upper arm, thigh or abdomen (belly) once every 4 weeks.
Det fås som et pulver, der opløses i den medfølgende væske og derefter gives som injektion.
It is available as a powder and a solvent to be made up into a solution for injection.
Det fås som filmovertrukne tabletter (62,5 mg og 125 mg) og som opløselige tabletter (32 mg).
It is available as ‘film-coated’ tablets (62.5 mg; 125 mg) and as dispersible tablets (32 mg).
Det fås som filmovertrukne tabletter (90, 180 og 360 mg) og som smeltetabletter (125, 250 og 500 mg).
It is available as film-coated tablets (90, 180 and 360 mg) and as dispersible tablets (125, 250 and 500 mg).
Det fås som fyldte injektionssprøjter (12, 30 eller 48 mio. enheder).
It is available as prefilled syringes (12, 30 or 48 million units).
Det fås som gulorange, kapselformede tabletter (100 mg).
It is available as yellow-to- orange, capsule-shaped tablets (100 mg).